This year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, LKF´s corporate philosophy is still the same. With its dedicated team, LKF supports clinical trials with an individual and study-oriented, flexible approach with consistent high-quality laboratory standards.
Foundation launches Harvard research hub
Latest NewsThe Novo Nordisk Foundation is investing US$47.5m into a research collaboration with the Broad Institute of MIT and Harvard, intending to dive into the disease mechanisms of diabetes and obesity.
Touchlight extends funding round to boost DNA vector manufacture
Latest NewsUK-based DNA synthesis specialist Touchlight Ltd has extended a funding round to a current aggregate total of US $125m.
Meatable teams up with Royal DSM
Latest NewsRoyal DSM is backing Meatable, the cultivated meat start-up, in order to develop growth media for cultivated meat.
What are the Ingredients of an mRNA Vaccine?
Sponsored PublicationsmRNA technology has revolutionized vaccine development. What are the chemical components that make up a typical mRNA vaccine and what are their functions? What analytical testing can be done to support this?
Do you really know what is in your vaccine?
ProductsCAD is a universal detector able to detect all non-volatile, and many semi-volatile analytes. This uniform response enables accurate quantitation of most excipients in a vaccine formulation.
LKF 30 years dedicated to clinical trials
Sponsored PublicationsThis year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, LKF´s corporate philosophy is still the same. With its dedicated team, LKF supports clinical trials with an individual and study-oriented, flexible approach with consistent high-quality laboratory standards.
Facelift for reusable pipette tip boxes
ProductsThe new box is now called Box 2.0. The new design is a consistent, modern further development of the original product outfit.
Change in Solys BioDyne Management
AppointmentsAt the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.
US$21m for microbiome therapies
Latest NewsEnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline.
Swiss Biotech Day shows great biopharma ambitions
Latest NewsThe Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel.